Thndr Claps
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic
No Result
View All Result
Thndr Claps

Thndr Claps » EGY Claps » Rameda acquires a new drug

Rameda acquires a new drug

by Ziad Amin
May 23, 2022
Rameda, Rameda pharmaceuticals, Rameda EGX, Healthcare EGX, RMDA EGX

The Clap
Rameda (RMDA) acquired a new drug that helps treat blood clots.

Why this matters
The company wants to benefit from the significant growth in drug sales in the market, which recorded 87% between 2018 & 2021.

The company expects that the new product to generate EGP 30 million in revenues, and to contribute EGP 14 million in earnings before taxes.

Rameda also clarified that it will have used 60% of its 2019 IPO proceeds once the acquisition is complete. 

To read Rameda’s full statement, click here.

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

Related Posts

PIF receives green bonds welcomed by investors 💸
Energy 🔋

PIF receives green bonds welcomed by investors 💸

by Omar El Shorafa
February 7, 2023
Impact46 launches its new fund 💰
Tech 📲

Impact46 launches its new fund 💰

by Omar El Shorafa
February 7, 2023
Zain KSA strikes agreement with AWS 🤝
Telecommunications☎

Zain KSA strikes agreement with AWS 🤝

by Omar El Shorafa
February 7, 2023
Mergers & Acquisitions 🤝

ADQ Holding reportedly in talks to acquire Telecom Egypt’s stake in Vodafone Egypt

by Shams Abbas
February 7, 2023
Energy🔋

Egypt’s hydrogen strategy to be revealed in a month

by Shams Abbas
February 7, 2023
Economy 🏙

Calls to bring back the Ministry of Investment are ringing louder

by Shams Abbas
February 7, 2023

Website

Community

Blog

Learn

© Thndr. All rights reserved

No Result
View All Result
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic

Disclaimer: Thndr does not provide investment advice, individual investors are responsible for their own decisions or can seek independent advice. The value of investments can go up and down. Thndr is a trading name of Thndr Securities Brokerage which is authorised and regulated by the Financial Regulatory Authority (FRA). Registered in Egypt (no. 804)..© Thndr. All rights reserved

 

Hello👋 We want you to be able to express your opinions on anything and everything finance and economics related to the Egyptian and US markets.

This is why we introduced Thndr Thinkers💭

Let’s go through some housekeeping notes before you jump into publishing your article to all Thndr Claps readers!

Type of Content📝 We want to see market-relevant content that shows good analysis, please! Base your articles on facts 

Don’t be shy, explain🗣 Flex your knowledge to us, and we’ll share it with all the readers!

Be Original🙏 Please don’t copy. No one likes a copycat. All submissions are welcome as long as they’re yours 

Make your title attractive🤩 A title is like the cover of your book. Attractive enough to make you look at the book but also clear enough to tell you what the book is about.

Clean🧹 We’re all humans and we all make mistakes. But please try and clean up the article so it’s clear for all the readers 

No promotional content🚫 We don’t publish promotional content.

Any questions about becoming a Thndr Thinker? Email thndrclaps@thndr.app and we’d be happy to help!

Normally, your article will be published within 24 hours of submission (if you followed the guidelines)